Debt-to-equity rose to 0.73 in 2026Q2 from 0.59 in 2023Q4, with total debt at $3.8B and goodwill representing 29% of total assets, posing impairment risk.
Smith & Nephew plc (SNN) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 4.39B | 4.1B | 4.42B | 4.03B | 3.86B | 4.42B | 4.66B | 3.22B | 3.08B | 2.73B | 2.53B | 2.48B | 2.44B | 2.26B | 2.14B | 2.21B | 2.15B | 2.08B | 1.99B | 1.92B | 1.65B | 1.56B | 1.22B | 1.06B | 858.02M | 765.09M | 797.29M | 1B | 947.63M | 927.89M | 966.71M |
| Cash & Short-Term Investments | 754M | 557M | 619M | 302M | 350M | 1.29B | 1.76B | 277M | 365M | 169M | 100M | 120M | 93M | 137M | 178M | 184M | 207M | 192M | 145M | 170M | 346M | 151M | 62.53M | 46.43M | 36.24M | 43.69M | 36.74M | 162.58M | 82.83M | 94.39M | 137.86M |
| Cash Only | 754M | 557M | 619M | 302M | 350M | 1.29B | 1.76B | 277M | 365M | 169M | 100M | 120M | 93M | 137M | 178M | 184M | 207M | 192M | 145M | 170M | 346M | 151M | 62.53M | 46.43M | 36.24M | 43.69M | 36.74M | 162.58M | 82.83M | 94.39M | 137.86M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.49B | 1.43B | 1.21B | 1.06B | 1.03B | 971M | 911M | 1.08B | 1.1B | 1.06B | 988M | 939M | 968M | 935M | 1.05B | 1.02B | 0 | 0 | 0 | 14M | 0 | 481M | 585.15M | 498.54M | 18.36K | 0 | 39.26K | 0 | 230.51K | 0 | 409.97M |
| Days Sales Outstanding | - | 84.62 | 75.83 | 69.66 | 71.88 | 68 | 72.92 | 76.86 | 82.17 | 80.89 | 77.24 | 73.96 | 76.53 | 78.44 | 92.9 | 86.85 | - | - | - | 1.52 | - | 68.8 | 89.19 | 86.44 | 0 | - | 0.01 | - | 0.05 | - | 81.73 |
| Inventory | 2.11B | 2.12B | 2.39B | 2.4B | 2.21B | 1.84B | 1.69B | 1.61B | 1.4B | 1.3B | 1.24B | 1.22B | 1.18B | 1.01B | 901M | 859M | 923M | 933M | 879M | 834M | 619M | 557M | 546.46M | 411.79M | 369.65M | 338.13M | 340.84M | 384.37M | 402.36M | 373.11M | 393.53M |
| Days Inventory Outstanding | 221.82 | 394.84 | 503.32 | 528.52 | 531.24 | 444.56 | 446.93 | 442.61 | 392.28 | 381.38 | 356.97 | 388.63 | 370.97 | 333.81 | 307.35 | 275.03 | 326.77 | 330.63 | 297.9 | 306.25 | 293.8 | 290.02 | 310.6 | 243.9 | 253.79 | 242.01 | - | - | - | - | - |
| Other Current Assets | 33M | -99M | 81M | 182M | 198M | 240M | 219M | 171M | 144M | 120M | 124M | 115M | 100M | 88M | 992M | 80M | 1.02B | 14M | 899M | 834M | 630M | 567M | 297M | 280M | 407.71M | 383.27M | 368.12M | 416.02M | 429.27M | 431.13M | 0 |
| Total Non-Current Assets | 6.63B | 6.35B | 5.93B | 5.96B | 6.11B | 6.5B | 6.35B | 6.08B | 4.98B | 5.13B | 4.82B | 4.69B | 4.87B | 3.56B | 3.5B | 2.54B | 2.58B | 2.48B | 2.52B | 2.54B | 1.59B | 1.42B | 1.7B | 1.17B | 1.14B | 833.67M | 640.61M | 584.15M | 555.07M | 499.24M | 474.88M |
| Property, Plant & Equipment | 1.61B | 1.64B | 1.42B | 1.47B | 1.46B | 1.51B | 1.45B | 1.32B | 1.06B | 1.05B | 982M | 932M | 891M | 816M | 793M | 783M | 787M | 753M | 725M | 742M | 635M | 589M | 556.81M | 460M | 412.02M | 356.77M | 375.04M | 437.59M | 484.19M | 466.18M | 442.68M |
| Fixed Asset Turnover | 0.00x | 3.76x | 4.09x | 3.77x | 3.58x | 3.44x | 3.15x | 3.88x | 4.62x | 4.54x | 4.75x | 4.97x | 5.18x | 5.33x | 5.22x | 5.45x | 5.03x | 5.01x | 5.24x | 4.54x | 4.38x | 4.33x | 4.30x | 4.58x | 4.34x | 4.42x | 4.52x | 4.14x | 3.61x | 3.72x | 4.14x |
| Goodwill | 3.24B | 3.11B | 3.03B | 2.99B | 3.03B | 2.99B | 2.93B | 2.79B | 2.34B | 2.37B | 2.19B | 2.01B | 2.03B | 1.26B | 1.19B | 1.1B | 1.1B | 1.09B | 1.19B | 1.23B | 640M | 582M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.11B | 882M | 1.03B | 1.11B | 1.24B | 1.4B | 1.49B | 1.57B | 1.21B | 1.37B | 1.41B | 1.5B | 1.75B | 1.05B | 1.06B | 423M | 426M | 412M | 376M | 419M | 191M | 91M | 719.85M | 481.07M | 510.91M | 273.47M | 229.72M | 119.71M | 46.97M | 31.91M | 31.34M |
| Long-Term Investments | 353.97M | 151M | 16M | 24M | 58M | 380M | 250M | 216M | 231M | 201M | 137M | 128M | 117M | 109M | 118M | -125M | 13M | 6M | 0 | 0 | 0 | -123M | 48.64M | -116.79M | 0 | 0 | 35.85M | 26.85M | 23.9M | 1.16M | 856.25K |
| Other Non-Current Assets | 515M | 228M | 103M | 87M | 153M | 15M | 33M | 35M | 16M | 16M | 0 | 13M | 7M | 183M | 173M | 142M | 28M | 14M | 19M | 20M | 10M | 133M | 241.38M | 266.07M | 212.13M | 203.43M | -36.74M | -162.58M | -82.83M | -94.39M | -137.86M |
| Total Assets | 11.01B | 10.46B | 10.35B | 9.99B | 9.97B | 10.92B | 11.01B | 9.3B | 8.06B | 7.87B | 7.34B | 7.17B | 7.31B | 5.82B | 5.64B | 4.75B | 4.73B | 4.57B | 4.51B | 4.46B | 3.23B | 2.98B | 2.92B | 2.22B | 1.99B | 1.6B | 1.44B | 1.59B | 1.5B | 1.43B | 1.44B |
| Asset Turnover | 0.00x | 0.59x | 0.56x | 0.56x | 0.52x | 0.48x | 0.41x | 0.55x | 0.61x | 0.61x | 0.64x | 0.65x | 0.63x | 0.75x | 0.73x | 0.90x | 0.84x | 0.83x | 0.84x | 0.76x | 0.86x | 0.86x | 0.82x | 0.95x | 0.90x | 0.99x | 1.18x | 1.14x | 1.16x | 1.21x | 1.27x |
| Asset Growth % | 9.1% | 0.99% | 3.67% | 0.21% | -8.74% | -0.84% | 18.42% | 15.39% | 2.45% | 7.11% | 2.47% | -1.9% | 25.55% | 3.14% | 18.85% | 0.3% | 3.68% | 1.26% | 1.05% | 38.07% | 8.57% | 1.94% | 31.35% | 11.52% | 24.66% | 11.22% | -9.36% | 5.53% | 5.29% | -1% | 13.29% |
| Total Current Liabilities | 2.05B | 1.59B | 1.53B | 2.27B | 1.72B | 2.13B | 1.69B | 1.56B | 1.47B | 1.35B | 1.35B | 1.34B | 1.16B | 1.07B | 930M | 1.14B | 914M | 863M | 968M | 2.29B | 816M | 1.01B | 828.99M | 566.43M | 508.82M | 623.98M | 603.42M | 599.2M | 623.45M | 590.99M | 617.87M |
| Accounts Payable | 1.25B | 1.16B | 1.08B | 1.02B | 1.03B | 1.04B | 891M | 941M | 854M | 873M | 807M | 808M | 807M | 751M | 646M | 549M | 617M | 596M | 544M | 508M | 405M | 426M | 153M | 133M | 227.87M | 211.29M | 171.35M | 207.63M | 213.1M | 198.7M | 199.51M |
| Days Payables Outstanding | 112.45 | 216.35 | 228.15 | 224.21 | 247.91 | 251.45 | 235.49 | 258.05 | 240.15 | 255.32 | 231.57 | 258.02 | 253.49 | 249.2 | 220.36 | 175.78 | 218.43 | 211.2 | 184.36 | 186.54 | 192.23 | 221.81 | 86.96 | 78.77 | 156.44 | 151.23 | - | - | - | - | - |
| Short-Term Debt | 508M | 83M | 2M | 710M | 111M | 435M | 279M | 26M | 167M | 29M | 84M | 44M | 37M | 42M | 36M | 303M | 57M | 45M | 115M | 1.44B | 119M | 227M | 32M | 173.21M | 244.79M | 160.91M | 122.61M | 93.72M | 143.7M | 147.29M | 188.72M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 223M | 149M | 231M | 229M | 187M | 150M | 167M | 190M | 203M | 173M | -63M | -37M | -16M | 171M | -8.67M | -410.71M | -472.65M | 69.31M | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 229M | 85M | 126M | 261M | 526M | 597M | 460M | 551M | 224M | 213M | 224M | 490M | 316M | 278M | 69M | 109M | 37M | 55M | 117M | 338M | 292M | 359M | 534.99M | 188.21M | 36.17M | 182.46M | 310.11M | 297.15M | 266.65M | 56.7M | 50.69M |
| Current Ratio | 2.14x | 2.57x | 2.89x | 1.77x | 2.25x | 2.08x | 2.76x | 2.06x | 2.10x | 2.03x | 1.88x | 1.84x | 2.10x | 2.10x | 2.31x | 1.94x | 2.36x | 2.42x | 2.05x | 0.84x | 2.02x | 1.54x | 1.48x | 1.86x | 1.69x | 1.23x | 1.32x | 1.67x | 1.52x | 1.57x | 1.56x |
| Quick Ratio | 1.11x | 1.25x | 1.33x | 0.72x | 0.96x | 1.21x | 1.76x | 1.03x | 1.15x | 1.06x | 0.95x | 0.94x | 1.08x | 1.16x | 1.34x | 1.18x | 1.35x | 1.33x | 1.14x | 0.47x | 1.26x | 0.99x | 0.82x | 1.14x | 0.96x | 0.68x | 0.76x | 1.03x | 0.87x | 0.94x | 0.93x |
| Cash Conversion Cycle | 109.37 | 263.11 | 351 | 373.97 | 355.21 | 261.11 | 284.36 | 261.42 | 234.3 | 206.94 | 202.63 | 204.57 | 194 | 163.05 | 179.89 | 186.1 | - | - | - | 121.22 | - | 137 | 312.82 | 251.56 | 97.35 | - | - | - | - | - | - |
| Total Non-Current Liabilities | 3.78B | 3.57B | 3.56B | 2.5B | 2.99B | 3.22B | 4.04B | 2.59B | 1.72B | 1.88B | 2.04B | 1.86B | 2.1B | 699M | 828M | 422M | 1.05B | 1.52B | 1.84B | 357M | 241M | 529M | 744.02M | 511.96M | 651.04M | 385.6M | 434.19M | 94.15M | 73.37M | 73.56M | 78.09M |
| Long-Term Debt | 3.08B | 3.03B | 3.12B | 2.17B | 2.56B | 2.71B | 3.2B | 1.85B | 1.3B | 1.42B | 1.56B | 1.43B | 1.66B | 335M | 416M | 1M | 642M | 1.12B | 1.36B | 36M | 0 | 196M | 292.7M | 194.64M | 264.61M | 246.83M | 267.21M | 32.64M | 21.25M | 24.14M | 22.78M |
| Capital Lease Obligations | 559.87M | 149M | 135M | 144M | 147M | 141M | 157M | 124M | 0 | 0 | 5M | 8M | 10M | 12M | 14M | 15M | 0 | 0 | 0 | 0 | 15M | 15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 112.96M | 40M | 31M | 9M | 36M | 144M | 141M | 167M | 99M | 97M | 94M | 77M | 98M | 50M | 61M | 66M | 69M | 31M | 46M | 57M | 35M | 48M | 78.45M | 110.54M | 90.2M | 0 | 83.04M | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 570M | 356M | 269M | 171M | 244M | 229M | 551M | 452M | 320M | 356M | 380M | 423M | 438M | 352M | 337M | 27M | 262M | 322M | 437M | 264M | 191M | 139M | 204.57M | 279.32M | 296.19M | 138.78M | 83.94M | 61.51M | 52.12M | 49.43M | 55.31M |
| Total Liabilities | 5.83B | 5.17B | 5.09B | 4.77B | 4.71B | 5.35B | 5.73B | 4.16B | 3.19B | 3.22B | 3.39B | 3.2B | 3.27B | 1.77B | 1.76B | 1.56B | 1.96B | 2.39B | 2.81B | 2.65B | 1.06B | 1.54B | 1.57B | 1.08B | 1.16B | 1.01B | 1.04B | 693.35M | 696.82M | 664.55M | 695.96M |
| Total Debt | 3.79B | 3.33B | 3.32B | 3.08B | 2.87B | 3.34B | 3.69B | 2.05B | 1.47B | 1.45B | 1.65B | 1.48B | 1.71B | 391M | 468M | 322M | 699M | 1.16B | 1.47B | 1.48B | 134M | 438M | 354.65M | 367.86M | 509.39M | 407.74M | 389.68M | 126.5M | 164.99M | 171.43M | 211.49M |
| Net Debt | 3.03B | 2.77B | 2.7B | 2.78B | 2.52B | 2.05B | 1.93B | 1.77B | 1.1B | 1.28B | 1.55B | 1.36B | 1.61B | 254M | 290M | 138M | 492M | 970M | 1.33B | 1.31B | -212M | 287M | 292.12M | 321.43M | 473.15M | 364.05M | 352.94M | -36.07M | 82.16M | 77.03M | 73.64M |
| Debt / Equity | 0.73x | 0.63x | 0.63x | 0.59x | 0.55x | 0.60x | 0.70x | 0.40x | 0.30x | 0.31x | 0.42x | 0.37x | 0.42x | 0.10x | 0.12x | 0.10x | 0.25x | 0.53x | 0.87x | 0.81x | 0.06x | 0.31x | 0.26x | 0.32x | 0.61x | 0.69x | 0.97x | 0.14x | 0.20x | 0.22x | 0.28x |
| Debt / EBITDA | 1.34x | 2.43x | 2.74x | 3.24x | 2.88x | 2.89x | 4.39x | 1.55x | 1.14x | 1.06x | 1.36x | 1.30x | 1.44x | 0.33x | 0.40x | 0.28x | 0.58x | 1.12x | 1.61x | 2.02x | 0.19x | 0.73x | 0.78x | 0.79x | 1.29x | 1.30x | 1.33x | 0.48x | 0.57x | 0.51x | 0.55x |
| Net Debt / EBITDA | 1.08x | 2.03x | 2.23x | 2.92x | 2.53x | 1.77x | 2.30x | 1.34x | 0.85x | 0.94x | 1.27x | 1.19x | 1.36x | 0.21x | 0.25x | 0.12x | 0.41x | 0.94x | 1.45x | 1.79x | -0.30x | 0.48x | 0.64x | 0.69x | 1.20x | 1.16x | 1.20x | -0.14x | 0.28x | 0.23x | 0.19x |
| Interest Coverage | 6.22x | 6.21x | 5.90x | 5.59x | 8.23x | 8.90x | 6.93x | 15.03x | 16.57x | 15.19x | 17.58x | 12.44x | 21.08x | 39.19x | 122.33x | 72.25x | 54.28x | 16.95x | 8.94x | 12.33x | 59.67x | 28.11x | 13.85x | 19.13x | 11.87x | - | 18.54x | 24.25x | 13.68x | 13.19x | 18.87x |
| Total Equity | 5.18B | 5.29B | 5.26B | 5.22B | 5.26B | 5.57B | 5.28B | 5.14B | 4.87B | 4.64B | 3.96B | 3.97B | 4.04B | 4.05B | 3.88B | 3.19B | 2.77B | 2.18B | 1.7B | 1.82B | 2.17B | 1.44B | 1.35B | 1.14B | 833.21M | 589.18M | 399.84M | 892M | 805.38M | 762.08M | 745.11M |
| Equity Growth % | 1.29% | 0.46% | 0.92% | -0.8% | -5.55% | 5.47% | 2.68% | 5.48% | 4.95% | 17.33% | -0.2% | -1.83% | -0.17% | 4.2% | 21.87% | 14.93% | 27.26% | 28.25% | -6.44% | -16.47% | 51.5% | 6.57% | 17.67% | 37.33% | 41.42% | 47.35% | -55.18% | 10.76% | 5.68% | 2.28% | 19.24% |
| Book Value per Share | 12.04 | 12.12 | 12.01 | 23.88 | 12.02 | 12.69 | 12.06 | 11.75 | 11.14 | 10.61 | 8.87 | 9.09 | 8.98 | 8.93 | 8.62 | 7.12 | 6.24 | 4.92 | 3.82 | 3.91 | 4.61 | 3.04 | 2.86 | 2.45 | 1.75 | 1.27 | 0.91 | 2.04 | 1.77 | 1.67 | 1.65 |
| Total Shareholders' Equity | 5.18B | 5.29B | 5.26B | 5.22B | 5.26B | 5.57B | 5.28B | 5.14B | 4.87B | 4.64B | 3.96B | 3.97B | 4.04B | 4.05B | 3.88B | 3.19B | 2.77B | 2.18B | 1.7B | 1.82B | 2.17B | 1.44B | 1.35B | 1.14B | 833.21M | 589.18M | 399.84M | 892M | 805.38M | 762.08M | 745.11M |
| Common Stock | 175M | 175M | 175M | 175M | 175M | 177M | 177M | 177M | 177M | 178M | 180M | 183M | 184M | 184M | 193M | 191M | 191M | 190M | 190M | 190M | 189M | 203M | 219.62M | 203.57M | 182.91M | 165.13M | 167.88M | 180.86M | 184.91M | 183.83M | 189.57M |
| Retained Earnings | 5.43B | 5.32B | 5.02B | 4.91B | 5.03B | 5.22B | 4.96B | 4.85B | 4.63B | 4.33B | 3.97B | 3.73B | 3.65B | 3.52B | 3.82B | 3.26B | 2.85B | 2.34B | 1.96B | 1.91B | 1.66B | 937M | 826.11M | 616.07M | 418.51M | 226.29M | 44.66M | 519.77M | 430.74M | 393.94M | 370.93M |
| Treasury Stock | -733M | -515M | -66M | -94M | -118M | -120M | -157M | -189M | -214M | -257M | -432M | -294M | -315M | -322M | -735M | -766M | -778M | -794M | -823M | -637M | -1M | -4M | -4M | -2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -307M | 20M | 0 | -385M | -439M | -328M | -311M | -306M | -322M | -211M | -360M | -244M | -53M | 130M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -416.47K | -442.1M | -475.56M | -523.17M | -473.23M | -418.9M | -401.58M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying SNN stock.
As of 2025, Smith & Nephew plc (SNN) had total assets of $10.46B including $4.10B in current assets.
Smith & Nephew plc (SNN) carries total debt of $3.33B, offset by $557.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Smith & Nephew plc (SNN) has total shareholders' equity (book value) of $5.29B ($12.12 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Smith & Nephew plc (SNN) reported a current ratio of 2.57x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Elevated debt and China VBP
Balance Sheet Expansion with Rising Leverage
Total assets grew to $11.0B in 2026Q2 from $10.0B in 2023Q4, per reported figures, while debt increased to $3.8B, indicating expansion funded partly by borrowing.
The balance sheet has expanded modestly over the past two years, with total assets rising from $10.0B in 2023Q4 to $11.0B in 2026Q2. However, this growth has been accompanied by a rise in total debt from $3.1B to $3.8B over the same period, suggesting that asset growth is increasingly debt-funded. The equity base has remained relatively flat around $5.2B, implying that retained earnings are being offset by other equity movements, possibly buybacks or dividends. This trend may indicate a shift towards leverage to support operational investments, but the stability of equity suggests limited organic capital generation.
Leverage Creep Amidst Manageable Debt
Debt-to-equity rose to 0.73 in 2026Q2 from 0.59 in 2023Q4, as per financial statements, with total debt at $3.8B, reflecting increased borrowing to fund growth initiatives.
The D/E ratio has climbed from 0.59 in 2023Q4 to 0.73 in 2026Q2, indicating a deliberate increase in financial leverage. Total debt now stands at $3.8B, up from $3.1B, while cash has increased to $754M, providing some buffer. The leverage level remains within a manageable range compared to peers like Stryker (D/E 0.73), but the upward trajectory warrants monitoring, especially in a rising rate environment. The company's ability to service this debt appears adequate given stable cash flows, but the incremental borrowing may signal a strategic shift towards M&A or capital returns, which could strain future flexibility if not executed prudently.
Asset Mix Reflects Intangible-Heavy Model
Goodwill of $3.2B represents 29% of total assets in 2026Q2, as reported in SEC filings, while PPE of $1.6B is modest, underscoring an asset-light but acquisition-driven business.
The asset base is dominated by goodwill and intangibles, which at $3.2B constitute roughly 29% of total assets, highlighting the company's history of acquisitions. In contrast, net PPE of $1.6B is relatively small, indicating a lower reliance on physical assets and a higher dependence on intellectual property and brand. This mix suggests that SNN's value is tied to its product portfolio and market position rather than tangible assets, which could pose impairment risks if growth expectations are not met. The modest PPE also implies that capital expenditure is not a major constraint, but the significant goodwill balance requires careful monitoring for potential write-downs.
Equity Stability Masked by Buybacks
Retained earnings grew to $5.4B in 2026Q2 from $5.0B in 2023Q4, per financial statements, yet total equity remained flat at $5.2B, suggesting significant capital returns to shareholders.
Despite a $400M increase in retained earnings over the period, total equity has remained essentially unchanged at $5.2B, implying that the company has been returning capital to shareholders through dividends and buybacks. The prior cash flow analysis noted $502M in buybacks in 2025Q4, which likely offset the retained earnings growth. This pattern indicates a commitment to shareholder returns, but it also means that the balance sheet is not accumulating a larger equity cushion. The stability of equity suggests that management is confident in cash generation, but it also limits the buffer against potential losses or downturns.
Liquidity Buffer Strengthens
Current ratio improved to 2.14 in 2026Q2 from 1.77 in 2023Q4, as per reported figures, with cash rising to $754M, indicating a stronger short-term liquidity position.
The current ratio has improved from 1.77 in 2023Q4 to 2.14 in 2026Q2, indicating that current assets now comfortably cover current liabilities. Cash has more than doubled from $302M to $754M over the same period, providing a solid buffer against operational shocks. This improvement suggests that working capital management has become more efficient, possibly due to better inventory and receivables control. The enhanced liquidity position reduces near-term refinancing risk and provides flexibility for strategic investments or debt repayment, though the absolute cash level remains modest relative to total debt.
Goodwill Impairment Risk Looms
Goodwill of $3.2B, as disclosed in financial statements, represents a significant 29% of total assets, and any impairment could erode equity and signal overpayment for past acquisitions.
The substantial goodwill balance, which has remained stable around $3.0-3.2B over the past ten quarters, is a key risk to the balance sheet's integrity. If the acquired businesses underperform, particularly in the orthopaedics or wound care segments, an impairment charge could directly reduce equity and net income. The company's history of restructuring charges and the competitive pressures in China (VBP) may increase the likelihood of such impairments. Investors should monitor segment performance and any indicators of goodwill impairment testing, as a write-down would not only impact the balance sheet but also signal that past acquisition synergies have not materialized as expected.